Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$32.16
neg -0.30
-0.94%
Today's Range: 32.12 - 32.50 | PFE Avg Daily Volume: 22,382,100
Last Update: 05/22/17 - 11:49 AM EDT
Volume: 7,518,847
YTD Performance: -0.06%
Open: $32.50
Previous Close: $32.46
52 Week Range: $29.83 - $37.39
Oustanding Shares: 5,967,844,470
Market Cap: 192,283,948,823
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 8
Moderate Buy 0 0 0 0
Hold 8 9 9 9
Moderate Sell 0 0 0 0
Strong Sell 1 0 0 0
Mean Rec. 2.25 2.13 2.13 2.06
Latest Dividend: 0.32
Latest Dividend Yield: 3.97%
Dividend Ex-Date: 05/10/17
Price Earnings Ratio: 27.08
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
27.08 27.10 29.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.45% -2.76% 10.86%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.10 0.00 0.01
Net Income 3.70 -0.40 -0.14
EPS 5.40 -0.60 -0.28
Earnings for PFE:
EBITDA 19.49B
Revenue 52.82B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.65 $0.65 $2.55 $2.76
Number of Analysts 7 6 9 8
High Estimate $0.67 $0.68 $2.58 $2.85
Low Estimate $0.62 $0.63 $2.54 $2.64
Prior Year $0.64 $0.61 $2.40 $2.55
Growth Rate (Year over Year) 1.56% 5.74% 6.39% 8.24%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Biotech investors should keep a close eye on the progress in this huge potential market.
These stocks should be part of a strong first-quarter earnings season.

Second-Quarter Picks and Pans Real Money Pro($)

Las Vegas Sands and Flexion are in, and the autos are out.
We know that we are in the era when index managers are ascendant.
Why the name is sagging, and what it will take to spur the sector higher.
Drug companies are the latest targets/beneficiaries.
Bull market number one, perhaps of all time: the financials.
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.

Columnist Conversations

we have a nice winner, we'll roll up SOLD MOMO JUL 40 CALL AT 7.1 (in at 4.2) BOUGHT MOMO JUL 45 CALL AT...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.